Navigation Links
Type of breast reconstruction impacts radiation therapy outcomes
Date:11/20/2008

For breast cancer patients who underwent a mastectomy who undergo radiation therapy after immediate breast reconstruction, autologous tissue reconstruction provides fewer long-term complications and better cosmetic results than tissue expander and implant reconstruction, according to a study in the November issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

After undergoing a mastectomy (surgical removal of the breast), many women choose to have a breast reconstruction procedure performed immediately to better cope with the psychological and esthetic side effects of the surgery. However, the reconstruction can complicate radiation therapy treatments and sometimes radiation can negatively affect the outcome of reconstruction and increase the risk of long-term complications.

With radiation therapy increasingly becoming the standard of care for high-risk breast cancer patients after mastectomy, this can cause a problem for both patients and their radiation oncologists.

Researchers at the Department of Radiation Oncology at Long Island Radiation Therapy in Garden City, N.Y., the Department of Surgery at Long Island Jewish Hospital in New Hyde Park, N.Y., the Department of Surgery at North Shore University Hospital in Manhasset, N.Y., and the Department of Surgery at Winthrop University Hospital in Mineola, N.Y., sought to determine if the type of reconstruction performed on women who were receiving radiation after a mastectomy had an impact on their long-term outcomes.

Two types of reconstruction are available for patients undergoing mastectomy for breast cancer: ATR (autologous tissue reconstruction), which involves the placement of a tissue flap most commonly from the transverse rectus abdominus muscle as a breast mound, and TE/I (tissue expander and implant reconstruction), which involves placing an inflatable tissue expander over
'/>"/>

Contact: Beth Bukata
bethb@astro.org
703-839-7332
American Society for Therapeutic Radiology and Oncology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...lth one of 63 businesses honored in Washington, D....Newswire/ -- Texas Health Resources has received... from the National Business Group on Health. , ,...090702/DC41773LOGO ) , , The award recognize... programs that promote a healthy workplace and for...
(Date:7/2/2009)...servation can help reduce threat, expert says , ...ncer is a major threat to certain species of wildl...itoring, researchers say. , "Cancer is one of t...for more than 10 percent of human deaths. But we n... similar rates," lead author Denise McAloose, chie...
(Date:7/2/2009)...p aid shuts down one set of neurons, another set w...althDay News) -- New information about brain circu...ake the sleep aid Ambien (zolpidem) walk, eat, tal...e -- and without remembering it the next morning. ...lly conscious patients into a conscious state. ,...
(Date:7/2/2009)...tistical and biological issues need to be addresse... early detection of cancer, according to a comment... National Cancer Institute . , The biomarker pip...ts includes the identification of promising biomar...efinitive evaluation of biomarkers for cancer scre...
Breaking Medicine News(10 mins):Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Cancer Endangers Some Wildlife Species 2Health News:Odd Behaviors on Ambien Linked to Brain Circuitry 2
...of a recent study researchers say that the circadi...epeat in 24-hour cycles , can significantly impact...ercise // or receive medical treatments . During t...n 8:00 a.m. and 5:00 p.m were examined. Results f...
... the most common cancer among men, affecting about...d 220,000 new cases // of the disease are diagnose...te cancer every year. New research shows men who a...lining of their prostate ducts run a high risk of ...
...ws that people who suffer from sleep apnea run a h...sia administered // during surgery . Sleep apnea i...iodically during sleep . Statistics show the most ...obstructive sleep apnea, affects as many as 4 perc...
...a laugh signifies more than humor and ridicule, re...cal evidence // of the role of laughter during psy...e about communicating emotion than about humor. Re...s and took physiological measurements of both memb...
Other Medicine News:
(Date:6/29/2009)...for Novel Biotherapeutics Based On Naturally Resec...RNewswire/ -- Pangu BioPharma, a subsidiary of aTy...of its third patent application on proprietary, na.... Although tRNA synthetases are universal and ess...ound in all organisms, human synthetases have natu...
(Date:6/26/2009)...e 26, and OSAKA, Japan, June 27, 2009 /PRNewswire/...") today announced that Takeda Global Research &am... States (U.S.) subsidiary received on June 26 (U.S...ood and Drug Administration (FDA) regarding the Co... a selective dipeptidyl peptidase IV (DPP-4) inhib...
(Date:6/25/2009)...Medical Experts Slated to Attend First National Sy...re/ -- The first national symposium designed to ex...held next week in New York City when thirteen top ...om their respective fields. The SUNY Youth Sports... the health impacts that the $5 billion-a-year ene...
(Date:6/24/2009)...e 25 In a revolutionary healthcare... in the British Journal of Nutrition (a Cambridge...tics reduce cholesterol and triglycerides, contr..., The controlled clinical study was conducted on ...n 80% survival rate to 24 months versus a 50% surv...
Breaking Medicine Technology:Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33% 2Education and progress at the 24th Annual EAU Congress in Stockholm 38671 1Education and progress at the 24th Annual EAU Congress in Stockholm 38671 2Stem cell breakthrough gives new hope to sufferers of muscle wasting diseases 7401 1Stem cell breakthrough gives new hope to sufferers of muscle wasting diseases 7401 2Magnetic nanoparticles navigate therapeutic genes through the body 7398 1NYU College of Dentistry awarded 241 9 million NIH grant for HIV research 7395 1NYU College of Dentistry awarded 241 9 million NIH grant for HIV research 7395 2
...cal Cancer and Other Human,Papillomavirus Related ...Large Phase III Clinical Studies Which Included Mo...icine publishes the most comprehensive,and robust ... , LYON, France, 10th May2007 – New clinical...cacy of Gardasil® in the,prevention of cervica...
...WIRE)--May 10, 2007 - GenVec, Inc.,(Nasdaq:GNVC) t...,the ability of the Company,s new adenovector, Ad3... eye. Lisa L. Wei, Ph.D., GenVec,s,Director of Pre...Serotype Adenovector Gives Long-Term Expression in...n and Ophthalmology ("ARVO"),Annual Meeting in For...
Other Medicine Technology:Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 7GenVec Presents Research on New Ad35 Adenovector at ARVO 2GenVec Presents Research on New Ad35 Adenovector at ARVO 3
Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Built on the market leading optical performance of the OMEGA 180, the OMEGA 500 has been optimized for even better views of the fundus. A new multi-coated illumination system, including a new XHL Xen
Medicine Products: